Business
AI summaryHyloris Pharmaceuticals SA is a specialty pharmaceutical company that reformulates and develops medicines, operating in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. Its portfolio includes products such as Maxigesic IV for post-operative pain, Sotalol IV for atrial fibrillation and ventricular arrhythmias, and Valacyclovir oral suspension for herpes infections, alongside a pipeline spanning cardiovascular, gastrointestinal, and other indications. The company works with partners including Pleco Therapeutics and AFT Pharmaceuticals, and is headquartered in Liege, Belgium.
